Michael Naumann

Michael Naumann is head of the Institute for Experimental Internal Medicine at the Otto von Guericke University. His research team investigates clinically important signaling modules that are relevant for cancer development. Suppression of cell death is a prominent feature of cancer cells, thus our work focuses on one of the most important regulatory systems involved in cell death and cell survival, the NF-kB network. In the era of personalized cancer medicine, address the state-of-the-art analysis of molecules involved in molecular pathogenesis. Herein, analyze proteins with a special emphasis on predictive indicators of disease. He contributes to the development of individually efficacious therapies with special expertise in gastric diseases and obesity. Within this specialization, define biomarkers and develop molecular assay systems.